{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2774, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de071-7475-77d8-b221-1589fffe0d72", "docSlug": "8dbd105918d4e9f25daa345dcf1853a0", "documentTitle": "Asos | Investor Day Presentation Deck | 56 slides", "authorId": "asos", "authorName": "ASOS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a timeline framework to map out specific diversity KPIs and recruitment process changes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-7475-77d8-b221-1589fffe0d72/46", "deckHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72", "deckAnchorHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72#slide-46", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 15, "beatId": "a00a1066-97a0-4654-82c7-4d91938eea09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The majority of the slides outline the solution, including specific goals, targets, and timelines.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-7475-77d8-b221-1589fffe0d72", "docSlug": "8dbd105918d4e9f25daa345dcf1853a0", "documentTitle": "Asos | Investor Day Presentation Deck | 56 slides", "authorId": "asos", "authorName": "ASOS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a timeline framework to map current initiatives against future goals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-7475-77d8-b221-1589fffe0d72/47", "deckHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72", "deckAnchorHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72#slide-47", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 15, "beatId": "a00a1066-97a0-4654-82c7-4d91938eea09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The majority of the slides outline the solution, including specific goals, targets, and timelines.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-7475-77d8-b221-1589fffe0d72", "docSlug": "8dbd105918d4e9f25daa345dcf1853a0", "documentTitle": "Asos | Investor Day Presentation Deck | 56 slides", "authorId": "asos", "authorName": "ASOS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a timeline framework to map out strategic initiatives leading to a 2030 KPI.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-7475-77d8-b221-1589fffe0d72/48", "deckHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72", "deckAnchorHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72#slide-48", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 15, "beatId": "a00a1066-97a0-4654-82c7-4d91938eea09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The majority of the slides outline the solution, including specific goals, targets, and timelines.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-7475-77d8-b221-1589fffe0d72", "docSlug": "8dbd105918d4e9f25daa345dcf1853a0", "documentTitle": "Asos | Investor Day Presentation Deck | 56 slides", "authorId": "asos", "authorName": "ASOS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 49, "slideType": "timeline", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-7475-77d8-b221-1589fffe0d72/49", "deckHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72", "deckAnchorHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72#slide-49", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 15, "beatId": "a00a1066-97a0-4654-82c7-4d91938eea09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The majority of the slides outline the solution, including specific goals, targets, and timelines.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-7475-77d8-b221-1589fffe0d72", "docSlug": "8dbd105918d4e9f25daa345dcf1853a0", "documentTitle": "Asos | Investor Day Presentation Deck | 56 slides", "authorId": "asos", "authorName": "ASOS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 50, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a vertical color-coded gradient bar on the left to indicate progress or sectioning.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-7475-77d8-b221-1589fffe0d72/50", "deckHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72", "deckAnchorHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72#slide-50", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 15, "beatId": "a00a1066-97a0-4654-82c7-4d91938eea09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The majority of the slides outline the solution, including specific goals, targets, and timelines.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-7475-77d8-b221-1589fffe0d72", "docSlug": "8dbd105918d4e9f25daa345dcf1853a0", "documentTitle": "Asos | Investor Day Presentation Deck | 56 slides", "authorId": "asos", "authorName": "ASOS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 51, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-7475-77d8-b221-1589fffe0d72/51", "deckHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72", "deckAnchorHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72#slide-51", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 15, "beatId": "a00a1066-97a0-4654-82c7-4d91938eea09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The majority of the slides outline the solution, including specific goals, targets, and timelines.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-7475-77d8-b221-1589fffe0d72", "docSlug": "8dbd105918d4e9f25daa345dcf1853a0", "documentTitle": "Asos | Investor Day Presentation Deck | 56 slides", "authorId": "asos", "authorName": "ASOS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 52, "slideType": "other", "function": "plan_implementation", "notes": "The slide uses a hierarchical organizational chart to illustrate reporting lines from working groups up to the PLC Board.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-7475-77d8-b221-1589fffe0d72/52", "deckHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72", "deckAnchorHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72#slide-52", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 15, "beatId": "a00a1066-97a0-4654-82c7-4d91938eea09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The majority of the slides outline the solution, including specific goals, targets, and timelines.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-7475-77d8-b221-1589fffe0d72", "docSlug": "8dbd105918d4e9f25daa345dcf1853a0", "documentTitle": "Asos | Investor Day Presentation Deck | 56 slides", "authorId": "asos", "authorName": "ASOS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 53, "slideType": "key_messages", "function": "summarize", "notes": "Slide 53 of a presentation. Features logos of CDP, TCFD, MSCI, and Sustainalytics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-7475-77d8-b221-1589fffe0d72/53", "deckHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72", "deckAnchorHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72#slide-53", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 15, "beatId": "a00a1066-97a0-4654-82c7-4d91938eea09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The majority of the slides outline the solution, including specific goals, targets, and timelines.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-7475-77d8-b221-1589fffe0d72", "docSlug": "8dbd105918d4e9f25daa345dcf1853a0", "documentTitle": "Asos | Investor Day Presentation Deck | 56 slides", "authorId": "asos", "authorName": "ASOS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 54, "slideType": "section_divider", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-7475-77d8-b221-1589fffe0d72/54", "deckHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72", "deckAnchorHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72#slide-54", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 15, "beatId": "a00a1066-97a0-4654-82c7-4d91938eea09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The majority of the slides outline the solution, including specific goals, targets, and timelines.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-7475-77d8-b221-1589fffe0d72", "docSlug": "8dbd105918d4e9f25daa345dcf1853a0", "documentTitle": "Asos | Investor Day Presentation Deck | 56 slides", "authorId": "asos", "authorName": "ASOS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 55, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a simple 2-column layout to categorize ESG goals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-7475-77d8-b221-1589fffe0d72/55", "deckHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72", "deckAnchorHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72#slide-55", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 15, "beatId": "a00a1066-97a0-4654-82c7-4d91938eea09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The majority of the slides outline the solution, including specific goals, targets, and timelines.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-7475-77d8-b221-1589fffe0d72", "docSlug": "8dbd105918d4e9f25daa345dcf1853a0", "documentTitle": "Asos | Investor Day Presentation Deck | 56 slides", "authorId": "asos", "authorName": "ASOS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 56, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-7475-77d8-b221-1589fffe0d72/56", "deckHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72", "deckAnchorHref": "/decks/019de071-7475-77d8-b221-1589fffe0d72#slide-56", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 15, "beatId": "a00a1066-97a0-4654-82c7-4d91938eea09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The majority of the slides outline the solution, including specific goals, targets, and timelines.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/siKn9He4ts8MiOdZzvL-iJNw3aTRfR38i9clPX5wPBU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83MDEzZDA5NjZiZmVkZDBkNzU3YjlmYTI0YTQ4MDQ1NS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/1", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/cJguggXRzJKC3K_Iupak2snYWmPli6Law4JCIBwWzfA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83MDEzZDA5NjZiZmVkZDBkNzU3YjlmYTI0YTQ4MDQ1NS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/f8RZphlNdphWWeQdDoQxCcXpyiFlbz_Yvf5aNjgBKkI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83MDEzZDA5NjZiZmVkZDBkNzU3YjlmYTI0YTQ4MDQ1NS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/E4CsB61sEhul4O36w0EBkINa9Zk8ncCpJyzYxfEGC4g/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83MDEzZDA5NjZiZmVkZDBkNzU3YjlmYTI0YTQ4MDQ1NS9wMDAxLnBuZw" }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/2", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/3", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/4", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "section_divider", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/5", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "other", "function": "present_framework", "notes": "The diagram uses a circular flow representing different therapeutic modalities (Immune engagers, Cell therapy, Oncolytic virus, Immuno-oncology, DNA damage response, Antibody drug conjugates, Radioimmuno-conjugates, Nanomedicines, Epigenetics).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/6", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-6", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "bc526df6-0425-4b12-88a3-db493ea6a117", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Introduction to cancer treatment challenges and Enhertu's potential", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "kpi_overview", "function": "summarize", "notes": "Includes a timeline of 5 years of Presidential Symposia/Presentations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/7", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-7", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "bc526df6-0425-4b12-88a3-db493ea6a117", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Introduction to cancer treatment challenges and Enhertu's potential", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "cover", "function": "front_matter", "notes": "The slide features a stylized silhouette of a person with a molecular/cellular visualization in the chest area.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/8", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-8", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "bc526df6-0425-4b12-88a3-db493ea6a117", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Introduction to cancer treatment challenges and Enhertu's potential", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "appendix_methodology", "function": "present_framework", "notes": "Clinical trial design diagram showing randomization between T-DXd and T-DM1.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/9", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-9", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 9, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "4c136f41-d14c-4c9d-b4d4-01b2328be5bb", "evidence": "The deck presents detailed trial data to support Enhertu's efficacy and safety.", "position": 1, "objective": "How does Enhertu's data support its potential as a standard of care?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "7d6fc11c-9c63-4d02-bc07-8fe706170a68", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Detailed data on Enhertu's efficacy and safety", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "appendix_methodology", "function": "analyze_data", "notes": "Standard clinical trial patient flow diagram.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/10", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-10", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 9, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "4c136f41-d14c-4c9d-b4d4-01b2328be5bb", "evidence": "The deck presents detailed trial data to support Enhertu's efficacy and safety.", "position": 1, "objective": "How does Enhertu's data support its potential as a standard of care?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "7d6fc11c-9c63-4d02-bc07-8fe706170a68", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Detailed data on Enhertu's efficacy and safety", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "comparison_table", "function": "analyze_data", "notes": "Waterfall plots show best percentage change in sum of diameters from baseline for two treatment arms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/11", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-11", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 9, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "4c136f41-d14c-4c9d-b4d4-01b2328be5bb", "evidence": "The deck presents detailed trial data to support Enhertu's efficacy and safety.", "position": 1, "objective": "How does Enhertu's data support its potential as a standard of care?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "7d6fc11c-9c63-4d02-bc07-8fe706170a68", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Detailed data on Enhertu's efficacy and safety", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "appendix_data", "function": "analyze_data", "notes": "Kaplan-Meier survival analysis plot with a risk table below.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/12", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-12", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 9, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "4c136f41-d14c-4c9d-b4d4-01b2328be5bb", "evidence": "The deck presents detailed trial data to support Enhertu's efficacy and safety.", "position": 1, "objective": "How does Enhertu's data support its potential as a standard of care?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "7d6fc11c-9c63-4d02-bc07-8fe706170a68", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Detailed data on Enhertu's efficacy and safety", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "appendix_data", "function": "analyze_data", "notes": "Kaplan-Meier survival analysis plot with a risk table at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/13", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-13", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 9, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "4c136f41-d14c-4c9d-b4d4-01b2328be5bb", "evidence": "The deck presents detailed trial data to support Enhertu's efficacy and safety.", "position": 1, "objective": "How does Enhertu's data support its potential as a standard of care?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "7d6fc11c-9c63-4d02-bc07-8fe706170a68", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Detailed data on Enhertu's efficacy and safety", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Clinical trial data presentation; includes 'Patients Still at Risk' table and statistical summary.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/14", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-14", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 9, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "4c136f41-d14c-4c9d-b4d4-01b2328be5bb", "evidence": "The deck presents detailed trial data to support Enhertu's efficacy and safety.", "position": 1, "objective": "How does Enhertu's data support its potential as a standard of care?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "7d6fc11c-9c63-4d02-bc07-8fe706170a68", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Detailed data on Enhertu's efficacy and safety", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "comparison_table", "function": "analyze_data", "notes": "The table compares safety profiles of two drugs across various adverse event categories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/15", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-15", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes footnotes regarding patient exclusions and definitions of LVEF events.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/16", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-16", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide highlights PFS, ORR, OS, and safety profile metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/17", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-17", "loopMatches": [ { "to": 17, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31", "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.", "position": 0, "objective": "What are the consequences of not adopting Enhertu as the standard of care?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 20, "from": 17, "beatId": "b84365e9-a163-4557-b2fe-beb8ac4c4175", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Key takeaways and future prospects for Enhertu", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a timeline-like arrow structure to represent lines of therapy (1L, 2L, 3L+).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/18", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 17, "beatId": "b84365e9-a163-4557-b2fe-beb8ac4c4175", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Key takeaways and future prospects for Enhertu", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "section_divider", "function": "transition", "notes": "The slide features a stylized silhouette of a person with a molecular/antibody illustration inside the chest area.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/19", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 17, "beatId": "b84365e9-a163-4557-b2fe-beb8ac4c4175", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Key takeaways and future prospects for Enhertu", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "timeline", "function": "summarize", "notes": "The slide uses a chronological progression (Today, 2022, Future) to frame the drug's market expansion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/20", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 17, "beatId": "b84365e9-a163-4557-b2fe-beb8ac4c4175", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Key takeaways and future prospects for Enhertu", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a matrix-like layout to map disease states (rows) against treatment lines (columns).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/21", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "section_divider", "function": "transition", "notes": "The slide features a stylized silhouette of a person with a molecular/antibody structure overlaid on the chest area.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/22", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 22, "beatId": "8cb9e789-5fbb-4a11-b0c1-ed4cb8d8efc0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Opportunities across treatment settings and cancers", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "comparison_table", "function": "analyze_data", "notes": "Slide presents two distinct clinical trial visualizations: a Kaplan-Meier survival curve and a waterfall plot.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/23", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 22, "beatId": "8cb9e789-5fbb-4a11-b0c1-ed4cb8d8efc0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Opportunities across treatment settings and cancers", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a color-coded system to distinguish between monotherapy (purple) and combination therapy (yellow) clinical trials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/24", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 22, "beatId": "8cb9e789-5fbb-4a11-b0c1-ed4cb8d8efc0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Opportunities across treatment settings and cancers", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide presents two distinct clinical data sets: a table for PACIFIC-R and a Kaplan-Meier survival curve for the COAST trial.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/25", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 22, "beatId": "8cb9e789-5fbb-4a11-b0c1-ed4cb8d8efc0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Opportunities across treatment settings and cancers", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Slide displays multiple clinical trial results (Kaplan-Meier curves and waterfall plots) across different drug combinations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/26", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "closing_ask", "function": "state_next_steps", "notes": "The slide features a stylized silhouette of a human head and torso with biological/molecular imagery inside.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/27", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/28", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/29", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide uses a process flow diagram to map eligibility criteria to specific patient cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/30", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "other", "function": "present_framework", "notes": "The slide uses a process flow diagram to illustrate the trial structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/31", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "appendix_methodology", "function": "present_framework", "notes": "Clinical trial design diagram showing patient flow from enrollment to treatment arms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/32", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "appendix_methodology", "function": "analyze_data", "notes": "Includes a table of clinical outcomes (PFS-10 months, ORR) and a risk table at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/33", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-753f-7227-aa1d-36a319c59353", "docSlug": "7013d0966bfedd0d757b9fa24a480455", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/34", "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353", "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/oYl-QX-gEKWlYOJfL4S_opfnjE--F2JpqriBAgAR_s0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zM2VmMGQ3ZTE5MDRmNTBjZDE3MGE1OWY0NTc5NjExOS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/1", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "218e1cd3-8b61-4634-b027-a5a93f5f22fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Is", "beatSlug": "sparkline-what-is-1", "evidence": "Slides 1-3 introduce the company, its purpose, vision, and values.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/9vJvXPth9w-fh3IxoEed-iVoWjh07-WmYizi28sX1Lg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zM2VmMGQ3ZTE5MDRmNTBjZDE3MGE1OWY0NTc5NjExOS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/eP93tYLB1bb5rxBgCwGb8UmPcomVjCQeTNuQFkz6MdY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zM2VmMGQ3ZTE5MDRmNTBjZDE3MGE1OWY0NTc5NjExOS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/6p0Z3Lj9ULHoGHhaoc5uSQmbU2UULrYctA7yqfqRd_M/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zM2VmMGQ3ZTE5MDRmNTBjZDE3MGE1OWY0NTc5NjExOS9wMDAxLnBuZw" }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/2", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "218e1cd3-8b61-4634-b027-a5a93f5f22fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Is", "beatSlug": "sparkline-what-is-1", "evidence": "Slides 1-3 introduce the company, its purpose, vision, and values.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "mission", "function": "inspire_vision", "notes": "The slide uses a split-layout with a blue sidebar for corporate identity and a large lifestyle image on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/3", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "218e1cd3-8b61-4634-b027-a5a93f5f22fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Is", "beatSlug": "sparkline-what-is-1", "evidence": "Slides 1-3 introduce the company, its purpose, vision, and values.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "other", "function": "establish_context", "notes": "The slide serves as a brand and product catalog overview.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/4", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "269dc8df-41a3-4433-95db-929962315e2f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Could Be", "beatSlug": "sparkline-what-could-be-2", "evidence": "Slides 4-6 discuss the industry-leading residential portfolio and growth opportunities.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a structured layout to present four strategic pillars alongside a right-hand column of key performance indicators.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/5", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "269dc8df-41a3-4433-95db-929962315e2f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Could Be", "beatSlug": "sparkline-what-could-be-2", "evidence": "Slides 4-6 discuss the industry-leading residential portfolio and growth opportunities.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "executive_summary", "function": "show_traction", "notes": "Mixed dashboard slide combining bar charts, KPI callouts, photo, and bullet list to summarize financial performance and competitive positioning.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/6", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "269dc8df-41a3-4433-95db-929962315e2f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Could Be", "beatSlug": "sparkline-what-could-be-2", "evidence": "Slides 4-6 discuss the industry-leading residential portfolio and growth opportunities.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a combination of market sizing and qualitative drivers (architect popularity, replacement cycle) to justify the growth thesis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/7", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-7", "loopMatches": [ { "to": 9, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "60bab689-cdf3-41a2-b1cd-cefbfd321c66", "evidence": "The market sizing and wood conversion opportunity slides imply the cost of inaction.", "position": 0, "objective": "Highlight the cost of not converting to AZEK's products", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "2919f8d1-ae15-46bb-abf4-6d597d4e6b5a", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Is", "beatSlug": "sparkline-what-is-3", "evidence": "Slides 7-9 provide market sizing and wood conversion opportunity details.", "position": 2, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "market_sizing", "function": "size_opportunity", "notes": "Uses a before-and-after visual comparison for product value proposition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/8", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-8", "loopMatches": [ { "to": 9, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "60bab689-cdf3-41a2-b1cd-cefbfd321c66", "evidence": "The market sizing and wood conversion opportunity slides imply the cost of inaction.", "position": 0, "objective": "Highlight the cost of not converting to AZEK's products", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "2919f8d1-ae15-46bb-abf4-6d597d4e6b5a", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Is", "beatSlug": "sparkline-what-is-3", "evidence": "Slides 7-9 provide market sizing and wood conversion opportunity details.", "position": 2, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "unfair_advantage", "function": "present_solution", "notes": "The slide uses a 2x2 grid layout to showcase four distinct product categories/technologies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/9", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-9", "loopMatches": [ { "to": 9, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "60bab689-cdf3-41a2-b1cd-cefbfd321c66", "evidence": "The market sizing and wood conversion opportunity slides imply the cost of inaction.", "position": 0, "objective": "Highlight the cost of not converting to AZEK's products", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "2919f8d1-ae15-46bb-abf4-6d597d4e6b5a", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Is", "beatSlug": "sparkline-what-is-3", "evidence": "Slides 7-9 provide market sizing and wood conversion opportunity details.", "position": 2, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "key_messages", "function": "summarize", "notes": "Includes a central flywheel diagram representing core values.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/10", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 10, "beatId": "645d7968-6a65-4266-975c-fb0d0c294400", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "New Bliss", "beatSlug": "sparkline-new-bliss", "evidence": "Slides 10-12 highlight the company's value creation model and growth prospects.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "business_model", "function": "present_framework", "notes": "The slide uses a layered chevron-based diagram to represent the business model.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/11", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 10, "beatId": "645d7968-6a65-4266-975c-fb0d0c294400", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "New Bliss", "beatSlug": "sparkline-new-bliss", "evidence": "Slides 10-12 highlight the company's value creation model and growth prospects.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "key_takeaways", "function": "summarize", "notes": "The growth equation is presented as a waterfall-style diagram.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/12", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 10, "beatId": "645d7968-6a65-4266-975c-fb0d0c294400", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "New Bliss", "beatSlug": "sparkline-new-bliss", "evidence": "Slides 10-12 highlight the company's value creation model and growth prospects.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "business_model", "function": "present_solution", "notes": "The slide uses a waterfall-style diagram to show margin drivers and a circular process diagram for the AIMS framework.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/13", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "key_messages", "function": "summarize", "notes": "Includes a visual representation of the product composition and a reference to a 2020 ESG report.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/14", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-75e5-7609-8e85-3fa91bc155cc", "docSlug": "33ef0d7e1904f50cd170a59f45796119", "documentTitle": "Azek | Investor Presentation Deck | 37 slides", "authorId": "azek", "authorName": "The AZEK Company", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "solution", "function": "present_solution", "notes": "Uses a before-after-bridge framing to show the transformation of waste into a premium product.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-75e5-7609-8e85-3fa91bc155cc/15", "deckHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc", "deckAnchorHref": "/decks/019de071-75e5-7609-8e85-3fa91bc155cc#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }